Media headlines about Healthequity (NASDAQ:HQY) have been trending somewhat positive on Friday, Accern Sentiment reports. Accern identifies positive and negative press coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Healthequity earned a daily sentiment score of 0.19 on Accern’s scale. Accern also assigned media coverage about the company an impact score of 45.1367849011795 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
Here are some of the headlines that may have impacted Accern Sentiment Analysis’s rankings:
- HealthEquity (HQY) Delivers Strong Sales Presentation at JPM Healthcare Conference; Network Partners Up 42% in … – StreetInsider.com (streetinsider.com)
- At $49.41, Is HealthEquity Inc (NASDAQ:HQY) A Buy? (finance.yahoo.com)
- HealthEquity (HQY) Delivers Strong Sales Presentation at JPM Healthcare Conference; Network Partners Up 42% in Fiscal 2018 (streetinsider.com)
- HealthEquity Announces Strong Sales, Presentation at JP Morgan Healthcare Conference (finance.yahoo.com)
Several equities analysts have recently commented on HQY shares. Chardan Capital boosted their target price on shares of Healthequity from $58.00 to $62.00 and gave the company a “buy” rating in a research report on Wednesday, December 6th. Zacks Investment Research upgraded shares of Healthequity from a “hold” rating to a “buy” rating and set a $60.00 target price for the company in a research report on Wednesday, November 8th. BidaskClub upgraded shares of Healthequity from a “sell” rating to a “hold” rating in a research report on Tuesday, November 7th. Citigroup started coverage on shares of Healthequity in a research report on Thursday, January 4th. They issued a “buy” rating for the company. Finally, Cantor Fitzgerald restated a “buy” rating and issued a $56.00 target price on shares of Healthequity in a research report on Monday, September 25th. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Healthequity has a consensus rating of “Buy” and an average target price of $58.33.
Healthequity (NASDAQ:HQY) last announced its quarterly earnings results on Tuesday, December 5th. The company reported $0.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.13 by $0.04. The company had revenue of $56.80 million for the quarter, compared to analyst estimates of $55.27 million. Healthequity had a net margin of 21.08% and a return on equity of 14.47%. The firm’s revenue was up 31.0% on a year-over-year basis. During the same period in the previous year, the firm posted $0.10 EPS. equities analysts predict that Healthequity will post 0.71 EPS for the current year.
In related news, major shareholder Berkley Capital, Llc sold 13,600 shares of Healthequity stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $51.02, for a total transaction of $693,872.00. Following the sale, the insider now directly owns 6,381 shares of the company’s stock, valued at approximately $325,558.62. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Ashley Dreier sold 10,000 shares of the business’s stock in a transaction that occurred on Monday, December 4th. The stock was sold at an average price of $50.97, for a total transaction of $509,700.00. Following the sale, the vice president now directly owns 15,652 shares in the company, valued at $797,782.44. The disclosure for this sale can be found here. Insiders have sold a total of 1,116,434 shares of company stock worth $58,417,878 over the last ninety days. 19.00% of the stock is currently owned by insiders.
TRADEMARK VIOLATION WARNING: This piece of content was reported by Week Herald and is the property of of Week Herald. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international trademark and copyright laws. The correct version of this piece of content can be viewed at https://weekherald.com/2018/01/12/somewhat-favorable-news-coverage-somewhat-unlikely-to-impact-healthequity-hqy-stock-price.html.
Healthequity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.